المؤلفون: Agarwal S; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Shane E; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Lang T; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Shiau S; Department of Biostatistics & Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA., Kamanda-Kosseh M; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Bucovsky M; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Lappe JM; Department of Medicine, Creighton University Medical Center, Omaha, NE, USA., Stubby J; Department of Medicine, Creighton University Medical Center, Omaha, NE, USA., Recker RR; Department of Medicine, Creighton University Medical Center, Omaha, NE, USA., Hu Y; Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY, USA., Wang Z; Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY, USA., Edward Guo X; Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY, USA., Cohen A; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2022 Jun 16; Vol. 107 (7), pp. e2690-e2701.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density Conservation Agents* , Osteoporosis*/diagnostic imaging , Osteoporosis*/drug therapy , Osteoporosis, Postmenopausal*/diagnostic imaging , Osteoporosis, Postmenopausal*/drug therapy, Bone Density ; Denosumab/pharmacology ; Denosumab/therapeutic use ; Female ; Humans ; Lumbar Vertebrae/diagnostic imaging ; Teriparatide

المؤلفون: Shane E; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Shiau S; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA., Recker RR; Department of Medicine, Creighton University Medical Center, Omaha, NE, USA., Lappe JM; Department of Medicine, Creighton University Medical Center, Omaha, NE, USA., Agarwal S; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Kamanda-Kosseh M; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Bucovsky M; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA., Stubby J; Department of Medicine, Creighton University Medical Center, Omaha, NE, USA., Cohen A; Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2022 Mar 24; Vol. 107 (4), pp. e1528-e1540.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density Conservation Agents* , Osteoporosis*/chemically induced , Osteoporosis*/drug therapy , Osteoporosis, Postmenopausal*/drug therapy, Bone Density ; Denosumab/pharmacology ; Denosumab/therapeutic use ; Female ; Humans ; Lumbar Vertebrae/diagnostic imaging ; Teriparatide

المؤلفون: Cohen A; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., Shiau S; Department of Epidemiology, Columbia University, Mailman School of Public Health, New York, New York., Nair N; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., Recker RR; Department of Medicine, Creighton University Medical Center, Omaha, Nebraska., Lappe JM; Department of Medicine, Creighton University Medical Center, Omaha, Nebraska., Dempster DW; Department of Pathology and Cell Biology, Columbia University College of Physicians & Surgeons, New York, New York.; Regional Bone Center, Helen Hayes Hospital, West Haverstraw, New York., Nickolas TL; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., Zhou H; Regional Bone Center, Helen Hayes Hospital, West Haverstraw, New York., Agarwal S; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., Kamanda-Kosseh M; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., Bucovsky M; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., Williams JM; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., McMahon DJ; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York., Stubby J; Department of Medicine, Creighton University Medical Center, Omaha, Nebraska., Shane E; Department of Medicine, Columbia University College of Physicians & Surgeons, New York, New York.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Oct 01; Vol. 105 (10).

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density/*drug effects , Bone Density Conservation Agents/*administration & dosage , Bone Remodeling/*drug effects , Osteoporosis/*drug therapy , Teriparatide/*administration & dosage, Absorptiometry, Photon ; Adult ; Female ; Humans ; Osteoporosis/metabolism ; Premenopause/metabolism ; Treatment Outcome

المؤلفون: Dempster DW; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Zhou H; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Recker RR; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Brown JP; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Recknor CP; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Lewiecki EM; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Miller PD; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Rao SD; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Kendler DL; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Lindsay R; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Krege JH; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Alam J; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Taylor KA; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Janos B; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada., Ruff VA; Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2016 Apr; Vol. 101 (4), pp. 1353-63. Date of Electronic Publication: 2016 Feb 09.

نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density Conservation Agents/*therapeutic use , Denosumab/*therapeutic use , Osteogenesis/*drug effects , Osteoporosis, Postmenopausal/*drug therapy , Parathyroid Hormone/*metabolism , Teriparatide/*therapeutic use, Aged ; Aged, 80 and over ; Anabolic Agents ; Drug Therapy, Combination ; Female ; Humans ; Middle Aged ; Osteoporosis, Postmenopausal/metabolism ; Osteoporosis, Postmenopausal/pathology

المؤلفون: Cohen A; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Kamanda-Kosseh M; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Recker RR; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Lappe JM; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Dempster DW; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Zhou H; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Cremers S; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Bucovsky M; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Stubby J; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993., Shane E; Columbia University (A.C., M.K.-K., S.C., M.B., E.S.), New York, New York 10032; Creighton University (R.R.R., J.M.L., J.S.), Omaha, Nebraska 68178; and Helen Hayes Hospital (D.W.D., H.Z.), West Haverstraw, New York 10993.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2015 Nov; Vol. 100 (11), pp. 4208-14. Date of Electronic Publication: 2015 Sep 10.

نوع المنشور: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density/*drug effects , Bone Density Conservation Agents/*therapeutic use , Osteoporosis, Postmenopausal/*drug therapy , Osteoporosis, Postmenopausal/*pathology , Teriparatide/*therapeutic use, Adult ; Aged ; Biomarkers/blood ; Bone Density Conservation Agents/adverse effects ; Bone Development/drug effects ; Female ; Humans ; Middle Aged ; Minerals/metabolism ; Pilot Projects ; Premenopause ; Spine/pathology ; Teriparatide/adverse effects ; Treatment Outcome ; Young Adult

المؤلفون: Nishiyama KK; Division of Endocrinology (K.K.N., A.C., P.Y., E.S.), Department of Medicine, and Department of Pathology (D.W.D.), College of Physicians and Surgeons, Columbia University, New York, New York 10032; Department of Biomedical Engineering (J.W., X.E.G.), Columbia University, New York, New York 10027; and Division of Endocrinology (J.M.L., R.R.R.), Department of Medicine, Creighton University, Omaha, Nebraska 68131., Cohen A, Young P, Wang J, Lappe JM, Guo XE, Dempster DW, Recker RR, Shane E

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2014 Jul; Vol. 99 (7), pp. 2418-25. Date of Electronic Publication: 2014 Mar 31.

نوع المنشور: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density/*drug effects , Bone Density Conservation Agents/*administration & dosage , Bone and Bones/*drug effects , Osteoporosis/*drug therapy , Teriparatide/*administration & dosage, Adult ; Bone and Bones/diagnostic imaging ; Female ; Fractures, Bone/prevention & control ; Humans ; Mechanical Phenomena/drug effects ; Middle Aged ; Osteoporosis/diagnostic imaging ; Osteoporosis/pathology ; Pilot Projects ; Premenopause/drug effects ; Tomography, X-Ray Computed/methods

المؤلفون: Cohen A; Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA., Stein EM, Recker RR, Lappe JM, Dempster DW, Zhou H, Cremers S, McMahon DJ, Nickolas TL, Müller R, Zwahlen A, Young P, Stubby J, Shane E

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2013 May; Vol. 98 (5), pp. 1971-81. Date of Electronic Publication: 2013 Mar 29.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Premenopause*, Bone Density Conservation Agents/*therapeutic use , Bone and Bones/*drug effects , Osteoporosis/*drug therapy , Teriparatide/*therapeutic use, Adult ; Biomarkers/blood ; Biomarkers/metabolism ; Bone Density/drug effects ; Bone Density Conservation Agents/adverse effects ; Bone and Bones/chemistry ; Bone and Bones/metabolism ; Bone and Bones/pathology ; Chemical Phenomena ; Collagen Type I/blood ; Collagen Type I/metabolism ; Drug Resistance ; Female ; Humans ; Middle Aged ; Osteoporosis/blood ; Osteoporosis/pathology ; Osteoporosis/physiopathology ; Osteoporotic Fractures/etiology ; Osteoporotic Fractures/prevention & control ; Peptide Fragments/blood ; Peptide Fragments/metabolism ; Peptides/blood ; Peptides/metabolism ; Pilot Projects ; Porosity ; Procollagen/blood ; Procollagen/metabolism ; Teriparatide/adverse effects ; Time Factors ; Young Adult

المؤلفون: Misof BM; Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria. barbara.misof@osteologie.at, Roschger P, Gabriel D, Paschalis EP, Eriksen EF, Recker RR, Gasser JA, Klaushofer K

المصدر: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2013 Mar; Vol. 28 (3), pp. 442-8.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8610640 Publication Model: Print Cited Medium: Internet ISSN: 1523-4681 (Electronic) Linking ISSN: 08840431 NLM ISO Abbreviation: J Bone Miner Res Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density Conservation Agents/*therapeutic use , Diphosphonates/*therapeutic use , Imidazoles/*therapeutic use, Biopsy ; Bone Density ; Bone Density Conservation Agents/administration & dosage ; Cohort Studies ; Diphosphonates/administration & dosage ; Humans ; Imidazoles/administration & dosage ; Infusions, Intravenous ; Placebos ; Zoledronic Acid

المؤلفون: Bala Y; INSERM UMR 1033 Equipe Qualité Osseuse et Marqueurs Biologiques, Faculté de Médecine Lyon Est, Claude Bernard (Domaine Laennec), Université de Lyon, 7-11 rue Guillaume Paradin, 69372, Lyon Cedex 08, France. yohannbala@gmail.com, Kohles J, Recker RR, Boivin G

المصدر: Calcified tissue international [Calcif Tissue Int] 2013 Jan; Vol. 92 (1), pp. 6-14. Date of Electronic Publication: 2012 Oct 23.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0827 (Electronic) Linking ISSN: 0171967X NLM ISO Abbreviation: Calcif Tissue Int Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density Conservation Agents/*therapeutic use , Diphosphonates/*therapeutic use , Osteoporosis, Postmenopausal/*drug therapy, Administration, Oral ; Aged ; Biopsy/methods ; Bone Density/drug effects ; Double-Blind Method ; Female ; Fractures, Bone/prevention & control ; Humans ; Ibandronic Acid ; Middle Aged ; Placebos ; Regression Analysis ; Reproducibility of Results ; Treatment Outcome

المؤلفون: Dempster DW; Regional Bone Center, Helen Hayes Hospital, West Haverstraw, New York 10993, USA. dempster@helenhayeshosp.org, Zhou H, Recker RR, Brown JP, Bolognese MA, Recknor CP, Kendler DL, Lewiecki EM, Hanley DA, Rao DS, Miller PD, Woodson GC 3rd, Lindsay R, Binkley N, Wan X, Ruff VA, Janos B, Taylor KA

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2012 Aug; Vol. 97 (8), pp. 2799-808. Date of Electronic Publication: 2012 Jun 14.

نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density Conservation Agents/*pharmacology , Bone and Bones/*drug effects , Diphosphonates/*pharmacology , Imidazoles/*pharmacology , Teriparatide/*pharmacology, Aged ; Aged, 80 and over ; Bone Remodeling ; Bone and Bones/pathology ; Cross-Sectional Studies ; Diphosphonates/adverse effects ; Double-Blind Method ; Female ; Humans ; Imidazoles/adverse effects ; Middle Aged ; Osteogenesis/drug effects ; Teriparatide/adverse effects ; Zoledronic Acid